Entos, the California-headquartered creator of a platform that utilizes artificial intelligence to design therapies, has secured $53 million in a funding round led by technology investor Coatue to support its breakthrough AI and quantum mechanics-driven drug design efforts.
By clicking “I Agree”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. View our Privacy Policy for more information.
